AUBURN, Ala. (WTVM) - The FDA has authorized Johnson & Johnson’s single-dose COVID-19 vaccine and the director of Auburn University’s medical clinic is calling the new vaccine a game changer.
In clinical trials, the vaccine is 72 percent effective against symptomatic infections. This is compared to Pfzier’s and Moderna’s more than 90 percent efficacy.
Dr. Frederick Kam says people shouldn’t focus on these numbers. The most important factor, according to Kam, is Johnson & Johnson’s vaccine is as effective in preventing hospitalizations and deaths as the other vaccines.
“What they should focus is, I don’t want to have a complicated case of COVID if I get infected. I don’t want to be hospitalized, and I don’t want to die. Focus less on the other part, as far as having clinical symptoms. If I had not been vaccinated already and I was eligible to get this vaccine, myself and my family, I would make sure all of us get the vaccine,” said Kam.
Kam says if the Alabama Department of Public Health offers the vaccine to Auburn University, the college will immediately start offering it.